The Executive Yuan yesterday approved two bills to govern regenerative medicine that aim to boost development of the field.
Taiwan would reach an important milestone in regenerative medicine development with passage of the regenerative medicine act and the regenerative medicine preparations ordinance, which would allow studies to proceed and treatments to be developed, Deputy Minister of Health and Welfare Victor Wang (王必勝) told reporters at a news conference after a Cabinet meeting.
Regenerative treatments have been used for several conditions, including cancer — by regenerating blood cells — and restoring joint function in soft tissue, Wang said.
Photo: Taipei Times
The draft legislation requires regenerative treatments to undergo human trials, he said.
“However, human trials might be waived if patients’ lives are in danger or in other extenuating circumstances,” he added.
Ministry of Health and Welfare Department of Civil Ethics Director-General Liu Yueh-ping (劉越萍) said that waivers for human trials would only be granted when people seek new treatments after other methods have failed.
The draft regenerative medicine bill stipulates that only government-certified medical institutions can administer such treatments, with individuals or organizations that administer them without permission to face fines of NT$2 million to NT$20 million (US$61,391 to US$613,911).
Non-medical institutions would face fines of NT$2 million to NT$20 million for advertising for the use of regenerative medical treatments, the bill says.
The bill also lists the conditions under which medical institutions could proceed with regenerative medical treatments without first conducting human trials.
People must have a life-threatening or severely debilitating disease, and Taiwan cannot have medication, equipment or technology that meets the need, while medical institutions can offer regenerative medical treatments that have been approved by the ministry before the bill is promulgated, it says.
The bill would also upgrade the status of the Ethical Guidelines Governing the Research of Human Embryos and Embryonic Stem Cell Research to law. The guidelines state that embryos and embryonic stem cells used in regenerative medical studies must not be produced through artificial insemination.
Moreover, embryos or embryonic stem cells acquired for research cannot be used to implant nucleated human ova in cell nuclei of other species, the guidelines say.
Researchers would be banned from acquiring research-use embryos for embryonic stem cells or using them to produce chimeric species that have human germ cells, the guidelines say.
The regenerative medicine preparations ordinance covers treatments that contain genes, cells and their derivatives for human use, including gene therapy, cell therapy and tissue engineering.
Pharmaceutical firms seeking to manufacture or import regenerative treatments must have their facilities inspected and registered, and they must be approved and issued a valid license to manufacture or import the products, the bill says.
Licenses would be valid for five years and can be extended for another five years if an extension is applied for three to six months in advanced and it is approved, the bill says.
To facilitate “compassionate treatment” for people with life-threatening illnesses for which other treatments are not available, the bill authorizes the ministry to approve under certain conditions the use of regenerative products after a phase 2 clinical trial has been completed and the product has been shown to be safe and effective.
Licenses for such products would be valid for five years and cannot be extended.
Both bills have regulations to protect people seeking regenerative treatment or medication.
The ministry has the authority to stop or terminate all or part of a regenerative treatments if a medical provider is facing an unusually high number of liability cases.
LOUD AND PROUD Taiwan might have taken a drubbing against Australia and Japan, but you might not know it from the enthusiasm and numbers of the fans Taiwan might not be expected to win the World Baseball Classic (WBC) but their fans are making their presence felt in Tokyo, with tens of thousands decked out in the team’s blue, blowing horns and singing songs. Taiwanese fans have packed out the Tokyo Dome for all three of their games so far and even threatened to drown out home team supporters when their team played Japan on Friday. They blew trumpets, chanted for their favorite players and had their own cheerleading squad who dance on a stage during the game. The team struggled to match that exuberance on the field, with
Taiwanese paleontologists have discovered fossil evidence that pythons up to 4m long inhabited Taiwan during the Pleistocene epoch, reporting their findings in the international scientific journal Historical Biology. National Taiwan University (NTU) Institute of Ecology and Evolutionary Biology associate professor Tsai Cheng-hsiu (蔡政修) led the team that discovered the largest snake fossil ever found in Taiwan. The single trunk vertebra was discovered in Tainan at the Chiting Formation, dated to between 400,000 and 800,000 years ago in the Middle Pleistocene, the paper said. The area also produced Taiwan’s first avian fossil, as well as crocodile, mammoth, saber-toothed cat and rhinoceros fossils, it said. Discoveries
Taiwanese paleontologists have discovered fossil evidence that pythons up to 4m long inhabited Taiwan during the Pleistocene epoch, reporting their findings in the international scientific journal Historical Biology. National Taiwan University (NTU) Institute of Ecology and Evolutionary Biology associate professor Tsai Cheng-hsiu (蔡政修) led the team that discovered the largest snake fossil ever found in Taiwan. A single trunk vertebra was discovered in Tainan at the Chiting Formation, dated to between 800,000 to 400,000 years ago in the Middle Pleistocene, the paper said. The area also produced Taiwan’s first avian fossil, as well as crocodile, mammoth, sabre-toothed cat and rhinoceros fossils, it said. Discoveries
Whether Japan would help defend Taiwan in case of a cross-strait conflict would depend on the US and the extent to which Japan would be allowed to act under the US-Japan Security Treaty, former Japanese minister of defense Satoshi Morimoto said. As China has not given up on the idea of invading Taiwan by force, to what extent Japan could support US military action would hinge on Washington’s intention and its negotiation with Tokyo, Morimoto said in an interview with the Liberty Times (sister paper of the Taipei Times) yesterday. There has to be sufficient mutual recognition of how Japan could provide